Sponsors

Bacteriophages vs. antibiotic resistance: opportunities in the latest scientific literature

In a post-pandemic world, it is perhaps counter-intuitive to suggest that viral agents could contribute to medicine’s fight against the rise of antimicrobial resistance. However, the use of bacteriophages against bacterial infection predates the antibiotic era, so what are some of the opportunities currently being explored? Here, Pathology in Practice Science Editor Brian Nation compiles a small selection of recent research interest.

Phage therapy for antibiotic-resistant bacterial infections

Hatfull GF, Dedrick RM, Schooley RT.
Annu Rev Med. 2022 Jan 27; 73: 197–211. doi: 10.1146/annurev-med-080219-122208.

Antibiotic resistance in bacterial pathogens presents a substantial threat to the control of infectious diseases. Development of new classes of antibiotics has slowed in recent years due to pressures of cost and market profitability, and there is a strong need for new antimicrobial therapies. 

Log in or register FREE to read the rest

This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text. If you don't already have an account, please register with us completely free of charge.

Latest Issues

The British Association for Cytopathology Annual Scientific Meeting

Aztec Hotel and Spa, Bristol, BS32 4TS
18 October, 2024

UK NEQAS: Navigating Quality Standards in Point of Care Testing

The Hyatt Regency Hotel, Birmingham, UK
23 October, 2024

Pathology Visions 24

Hyatt Regency, Orlando, FL
3-5 November, 2025

Medica

Messe Dusseldorf
11-14 November, 2024

POCT-for-Scot: Bringing the future to you

SEC Arena, Glasgow
14 November, 2024